In this issue:
HBV reactivation in MM in the era of novel agents
Two daratumumab regimens for MM
Carfilzomib improves PFS in high-risk MM
Necrobiotic xanthogranuloma associated with monoclonal gammopathies
Bence Jones proteinuria and other predictors of smouldering MM progression
C-myc overexpression associated with adverse features and worse OS in MM
Please login below to download this issue (PDF)